Application 211534
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SILDENAFIL CITRATE | SILDENAFIL CITRATE | FOR SUSPENSION;ORAL | EQ 10MG BASE/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0591-4050 | Sildenafil | Sildenafil | Actavis Pharma, Inc. | ANDA | Current |
| 0591-4050 | Sildenafil | Sildenafil | Actavis Pharma, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 60150 | ORIG | 2019-09-30 |